Idenix Pharmaceuticals (IDIX)

[laker9029]

<<trading appears to be confused with respect to what the new agreement means>>

Unfortunately, the PR was written as if Tyzeka had failed and the restructuring was done because the wheels had fallen off. Also, it may be that the market cannot evaluate the move because the projected revenues and the royalty rate are not stated. I view this positively -- moving global marketing and sales to Novartis, who is much better equipped to handle it, reaping the benefits of a dramatic improvement in cash burn, focusing on new product development, with an assured and perhaps growing stream of royalty income from Tyzeka.

Could Tyzeka sales grow enough to make the company cash flow positive?

L